Stabilized HNF4A saRNA compositions and methods of use
US11447773B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2018 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Oct 1, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.